~6 spots leftby Mar 2026

Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients

Recruiting in Palo Alto (17 mi)
Overseen byKyle Staller, MD, MPH
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: Massachusetts General Hospital
Prior Safety Data

Trial Summary

What is the purpose of this trial?Constipation is a known complication of the postoperative period after spinal surgery, where prescription pain medicines called opioids are traditionally used in high doses for the treatment of surgery-related pain. The goal of this study is to determine the effectiveness of Movantik (naloxegol)-a FDA-approved drug used to treat constipation that is caused by opioids-in preventing constipation in patients undergoing spinal fusion surgery at MGH.

Eligibility Criteria

Inclusion Criteria

Male or female patients between the ages of 18 and 75 years undergoing non-urgent, elective spinal fusion at Massachusetts General Hospital who are admitted to the neurosurgery floor from the operating room

Participant Groups

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MOVANTIK™ (naloxegol)Experimental Treatment1 Intervention
Subjects in the treatment group will be administered MOVANTIK™ (naloxegol) 25 mg tablet or placebo once daily beginning 2 hours after the completion of their surgery until their discharge from the hospital (variable timing). Subjects with renal impairments (creatine clearance rate of less than 60 mL/min) will receive a 12.5 mg dose tablet of naloxegol in place of the 25 mg dose as advised by FDA guidelines. For patients who are unable to swallow the tablet whole, the tablet can be crushed and given orally or administered via nasogastric tube.
Group II: Sugar pillPlacebo Group1 Intervention
Matching placebo consists of an inert mixture supplied by AstraZeneca in identical-appearing tablets. Subjects in the placebo group will be administered a placebo tablet once daily beginning 2 hours after the completion of their surgery until their discharge from the hospital (variable timing).

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Massachusetts General HospitalBoston, MA
Loading ...

Who Is Running the Clinical Trial?

Massachusetts General HospitalLead Sponsor
AstraZenecaIndustry Sponsor

References